Bio-Techne
TECH
#1525
Rank
A$17.41 B
Marketcap
$109.60
Share price
0.32%
Change (1 day)
12.79%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Revenue for Bio-Techne (TECH)

Revenue in 2024 (TTM): A$1.75 Billion

According to Bio-Techne's latest financial reports the company's current revenue (TTM ) is A$1.78 Billion. In 2023 the company made a revenue of A$1.68 Billion an increase over the revenue in the year 2022 that were of A$1.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bio-Techne from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$1.75 B4.36%
2023 A$1.68 B2.13%
2022 A$1.64 B15.88%
2021 A$1.42 B36.68%
2020 A$1.03 B-2.31%
2019 A$1.06 B9.92%
2018 A$0.96 B26.04%
2017 A$0.76 B4.79%
2016 A$0.73 B14.76%
2015 A$0.63 B27.91%
2014 A$0.49 B34.86%
2013 A$0.37 B23.12%
2012 A$0.30 B0.55%
2011 A$0.29 B11.39%
2010 A$0.26 B-8.95%
2009 A$0.29 B-22.54%
2008 A$0.38 B39.36%
2007 A$0.27 B1.67%
2006 A$0.26 B2.78%
2005 A$0.26 B20.26%
2004 A$0.21 B5.28%
2003 A$0.20 B-15.59%
2002 A$0.24 B2.35%
2001 A$0.23 B23.11%
2000 A$0.19 B30.36%
1999 A$0.14 B15.23%
1998 A$0.12 B32.54%
1997 A$97.46 M34.19%
1996 A$72.63 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$65.11 B 3,553.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.96 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.48 B 1,610.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.79 B 1,628.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.98 B 67.39%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$83.66 B 4,594.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$49.06 M-97.25%๐Ÿ‡บ๐Ÿ‡ธ USA